Figure 1. Body weight change of MCD-diet induced mice with/without treatment.
Figure 2. Liver weight changes of each experimental groups.
Figure 3. Effects of CE on blood lipid levels in C57BL/6J mice by biochemistry.
Figure 4. The effect of CE on the liver histology in MCD-diet-induced mice.
Figure 5. Effects of CE on MCD-diet induced liver function in C57BL/6J mice by biochemistry.
Figure 6. Effects of CE on hepatic lipid accumulation related protein and mRNA expression in liver tissue of experimental mice.
Figure 7. Effects of CE on lipogenesis related protein expression in liver tissue of experimental mice.
Figure 8. Effects of CE on AMPK phosphorylation in liver tissue of experimental mice.
Table 1. Sequences of oligonucleotide primers designed for PCR.
참고문헌
- Seo BI, Lee JH, Choi HY, Kwon DY and Boo YM. Herbology. Seoul : Younglimsa press. 2012:515-517.
- Son CW, Chae JK, Kim GW and Shin HM. Effects of Cragaegi Fructus on the Vascular Relaxation and Antioxidateive Status. Korean J of Oriental Medical Physiology & Pathology. 2002;16(1):67-71.
- Chon JW, Park JK, Lee MA, Jeong MR, Han JH, Park YK. Fermented Crataegi fructus vinegar improves lipid metabolism in ratsfed high fat diet. J Korean SocFood Sci Nutr. 2009;38(8):1024-1031. https://doi.org/10.3746/jkfn.2009.38.8.1024
- Tadic VM, Dobric S, Markovic GM, Dordevic SM, Arsic IA, Menkovic NR, and Stevic T. Antiinflammatory, gastroprotective, free radical scavenging and antimicrobial activities of hawthorn berries ethanol extract. J Agric Food Chem. 2008;56(17):7700-7709. https://doi.org/10.1021/jf801668c
- Kim KH, Lee SS, Baek JW, Lee SJ and Kim KH. Effect of Crataegii fructus on antioxidant capacity in D-galactose induced aging rats. Korean J Oriental Preventive Medical Soc. 2004;8:65-80.
- Seo BI. Preventive effects of water extracts form Crataegi fructuson hyperlipiderma and liverdamageinduced byalcohol. Korean J Herbology. 2005;20(1):35-43.
- Ko JS. Dermatology. Seoul:Soomoonsa Press. 2000;73.
- Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hobbs HH Hepatology. 2004;40(6):1387-1395. https://doi.org/10.1002/hep.20466
- Bedogni G, Miglioli L, Masutti F, Castiglione A, Croce LS, Tiribelli C. Incidence and natural course of fatty liver in the general population: the Dionysos study. Bellentani S Hepatology. 2007; 46(5):1387-1391. https://doi.org/10.1002/hep.21827
- Cabanes JS, Chazarra S, Garcia-Carmona F. Kojic acid, a cosmetic skin whitening agent, is a slow binding inhibitor of catecholase activity of tyrosinase. J Pharm Pharmacol. 1994;46:982-985. https://doi.org/10.1111/j.2042-7158.1994.tb03253.x
- Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrialdys functionin NASH: causes, consequences and possible means to prevent it. Mitochondrion. 2006;6:1-2.
- Eberle D, Hegarty B, Bossard P, Ferre P and Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004;86(11):839-848. https://doi.org/10.1016/j.biochi.2004.09.018
- Shimomura I, Bashmakov Y, Horton JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem. 1999;274:30028-30032. https://doi.org/10.1074/jbc.274.42.30028
- Winder WW, Hardie DG: AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol. 1999;277:E1-10.
- Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell. Annu Rev Biochem. 1998;67:821-855. https://doi.org/10.1146/annurev.biochem.67.1.821
- Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole -4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells. Eur J Biochem. 1995;229(2):558-565. https://doi.org/10.1111/j.1432-1033.1995.tb20498.x
- Louis NA, Witters LA. Glucose regulation of acetyl-CoA carboxylase in hepatoma and islet cells. J Biol Chem. 1992;267(4):2287-2293.
- Yang J, Maika S, Craddock L, King JA, Liu ZM. Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice. Biochem Biophys Res Commun. 2008;370:248-253. https://doi.org/10.1016/j.bbrc.2008.03.094
- McGowan MW, Artiss JD, Strandbergh DR. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. J Clin Chem. 1983;29:538.
- Richmond W. Use of cholesterol oxidase for assay of total and free cholesterol in serum by continuous flow analysis. J Clin Chem. 1976;22:1579.
- Noma A, Nakayama KN, Kota M, Okabe H. Simultaneous determin ation of serum cholesterol in high and low density lipoprotein with use of heparin, Ca2+ and an anion exchange resin. J Clin Chem. 1978;24:1504.
- Bacon BR. Genetic, metabolic, and infiltrative diseases affecting the liver. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill. 2008;1980-1983.
- Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-1231. https://doi.org/10.1056/NEJMra011775
- Suzuki A, Angulo P, Lymp J, Sauver J St, Muto A, Okada T, Lindor K. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology. 2005;41(1):64-71. https://doi.org/10.1002/hep.20543
- Yun JW, Cho YK. Clinical impact of non-alcoholic fatty liver disease on other medical diseases. Korean J Intern Med. 2009;76(1):25-29.
- Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114(2):147-152. https://doi.org/10.1172/JCI22422
- Rinella ME, Elias MS, Smolak RR, Fu T, Borensztajn J, Green RM. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J Lipid Res. 2008;49(5):1068-1076. https://doi.org/10.1194/jlr.M800042-JLR200
- Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis. 2002;6(2):399-420. https://doi.org/10.1016/S1089-3261(02)00002-8
- Leevy CM. Fatty liver. A study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine. 1962;41:249-276. https://doi.org/10.1097/00005792-196209000-00003
- Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12:1106-1110. https://doi.org/10.1002/hep.1840120505
- Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Path. 1989;20:594-598. https://doi.org/10.1016/0046-8177(89)90249-9
- Bacon BR, Faragvash MJ, Janny CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an espanded clinical entity. Gastroenterology. 1994;107:1103-1109. https://doi.org/10.1016/0016-5085(94)90235-6
- Gervois P, Torra IP, Fruchart JC, Staels B. Regulation of lipid and lipoprotein metabolism by PPAR activators. Clin Chem Lab Med. 2000;38:3-11.
- Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006;4(4):263-273. https://doi.org/10.1016/j.cmet.2006.07.001
- Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol. 2007;8(10):774-785 https://doi.org/10.1038/nrm2249
- Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, Andreelli F, Foretz M. AMP-activated protein kinasein there gulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf). 2009;196:81-98. https://doi.org/10.1111/j.1748-1716.2009.01970.x